Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2024		Jun. 30, 2023
Cash flows from operating activities
Net loss	$ (22,312)		$ (3,269)
Adjustments to reconcile net loss to cash used in operating activities:
Non-controlling interest	13		6
Gain on bargain purchase	0		(283)
Inventory reserve	257		373
Stock based compensation expense	5,929		852
Depreciation and amortization	10,335		2,322
Right-of-use assets, non-cash lease expense	760		660
Bad debts expense	1,993		598
Deferred income taxes	1,021		(24)
Shares issued for transaction bonuses	889		0
Other non-cash items	482		27
Changes in operating assets and liabilities:
Accounts receivables	(6,973)		(668)
Inventories	(624)		389
Prepaid expenses and other current assets	(1,518)		344
Deferred costs	(1,789)		185
Deferred revenue	(142)		58
Accounts payable and accrued expenses	4,993		(1,466)
Lease liabilities	(927)		(650)
Accrued severance payable, net	(2)		88
Net cash used in operating activities	(7,615)		(458)
Cash flows from investing activities
Acquisition, net of cash assumed	27,531		0
Capitalized software development costs	(2,308)		(997)
Capital expenditures	(5,586)		(966)
Net cash (used in)/provided by investing activities	19,637		(1,963)
Cash flows from financing activities
Repayment of long-term debt	(493)		(1,329)
Short-term bank debt, net	4,161		2,737
Purchase of treasury stock upon vesting of restricted stock	(2,836)		(4)
Payment of preferred stock dividend and redemption of preferred stock	(90,298)		(1,129)
Proceeds from exercise of stock options, net	0		36
Cash paid on dividends to affiliates	(4)		0
Net cash from/(used in) financing activities	(89,470)		311
Effect of foreign exchange rate changes on cash and cash equivalents	(823)		(941)
Net decrease in cash and cash equivalents, and restricted cash	(78,271)		(3,051)
Cash and cash equivalents, and restricted cash at beginning of the period	109,664		25,089
Reconciliation of cash and cash equivalents, and restricted cash
Cash and cash equivalents	24,354	[1]	24,780
Restricted cash	1,151		309
Cash, cash equivalents, and restricted cash	31,393		22,038
Supplemental disclosure of cash flow information:
Taxes	41		101
Interest	3,057		238
Noncash investing and financing activities:
Common stock issued for transaction bonus	9		0
Shares issued in connection with MiX Combination	$ 362,005		$ 0

[1] Derived from audited balance sheet as of March 31, 2024.